logo
Consumer group accuses Shein of manipulating shoppers with 'dark patterns'

Consumer group accuses Shein of manipulating shoppers with 'dark patterns'

CBC05-06-2025
Social Sharing
A consumer organization filed a complaint with the European Commission on Thursday against online fast-fashion retailer Shein over its use of "dark patterns," which are tactics designed to make people buy more on its app and website.
Pop-ups urging customers not to leave the app or risk losing promotions, countdown timers that create time pressure to complete a purchase and the infinite scroll on its app are among the methods Shein uses that could be considered "aggressive commercial practices," wrote BEUC, a pan-European consumer group, in a report.
The BEUC also detailed Shein's use of frequent notifications, with one phone receiving 12 notifications from the app in a single day.
"For fast fashion you need to have volume, you need to have mass consumption, and these dark patterns are designed to stimulate mass consumption," said Agustin Reyna, director general of BEUC, in an interview.
"For us, to be satisfactory they need to get rid of these dark patterns, but the question is whether they will have enough incentive to do so, knowing the potential impact it can have on the volume of purchases."
WATCH | How dark patterns are regulated by Canadian law:
How dark patterns in web design are regulated under Canadian law
2 years ago
Duration 2:09
A U.S. regulator sued Amazon last month for allegedly duping customers into buying Prime memberships using a web design trick called 'dark patterns.' Here's what Canada is doing about the practice.
A Shein spokesperson said in a statement that the company is "already working constructively with national consumers authorities and the EU Commission to demonstrate our commitment to complying with EU laws and regulations." It added that the BEUC had not accepted its request for a meeting.
Gameification used to drive shoppers to app
The BEUC also targeted the online discount platform Temu, a Shein rival, in a previous complaint.
Both platforms have surged in popularity in Europe, partly helped by apps that encourage shoppers to engage with games and stand to win discounts and free products.
Shein's use of gameification, drawing shoppers to use the app regularly, has helped drive its success.
In the "Puppy Keep" game on the app, users feed a virtual dog and collect points to win free items. They can gain more points by scrolling through the app, and by ordering items, but must log into the game every day or risk losing cumulative rewards.
The BEUC noted that dark patterns are widely used by mass-market clothing retailers and called on the consumer protection network to include other retailers in its investigation.
It said 25 of its member organizations in 21 countries, including France, Germany and Spain, joined in the grievance filed with the commission and with the European consumer protection network.
Late last month, the European Commission notified Shein of practices breaching EU consumer law and warned it would face fines if it failed to address the concerns.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Imagen Network Integrates Grok AI to Deliver More Personalized and Engaging Social Experiences
Imagen Network Integrates Grok AI to Deliver More Personalized and Engaging Social Experiences

Globe and Mail

time3 hours ago

  • Globe and Mail

Imagen Network Integrates Grok AI to Deliver More Personalized and Engaging Social Experiences

Next-gen personalization engines redefine interaction quality in decentralized networks London, United Kingdom--(Newsfile Corp. - August 14, 2025) - Imagen Network (IMAGE) has integrated Grok AI into its decentralized social ecosystem, bringing powerful personalization capabilities to user experiences. This integration allows Imagen to optimize content delivery, peer discovery, and engagement strategies in real-time, ensuring users connect with the most relevant communities and conversations. Driving intelligent connections in the decentralized social landscape. To view an enhanced version of this graphic, please visit: Grok's advanced inference and contextual processing enable Imagen Network to fine-tune feeds dynamically, fostering a more meaningful and engaging social environment. This advancement empowers creators, curators, and community leaders to deliver targeted and adaptive interactions without compromising decentralization. The initiative underscores Imagen's dedication to building an AI-enhanced, user-first Web3 social framework, positioning the platform as a leader in intelligent and adaptive community infrastructure. About Imagen Network Imagen Network leverages decentralized technology to create AI-powered social systems that prioritize personalization, engagement, and transparency. The platform's tools empower creators, communities, and users to connect and collaborate in innovative ways. Media Contact Dorothy Marley KaJ Labs +1 707-622-6168 media@ Social Media Twitter Instagram To view the source version of this press release, please visit

NuScale Power's Earnings Call Highlights Growth and Challenges
NuScale Power's Earnings Call Highlights Growth and Challenges

Globe and Mail

time6 hours ago

  • Globe and Mail

NuScale Power's Earnings Call Highlights Growth and Challenges

Nuscale Power Corporation ((SMR)) has held its Q2 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The recent earnings call for NuScale Power Corporation conveyed a generally positive sentiment, underscored by significant advancements in regulatory approvals and revenue growth. However, the call also highlighted challenges such as rising operating expenses and project delays in Romania. Despite these hurdles, the company's strategic partnerships and educational initiatives are bolstering its position in the Small Modular Reactor (SMR) market. NRC Approval for 77-Megawatt Design NuScale Power has achieved a significant milestone by receiving a second NRC approval for its 77-megawatt electric design. This accomplishment positions NuScale as the only SMR technology with such approvals, paving the way for closer steps towards commercialization. Significant Revenue Increase The company reported a substantial increase in revenue, reaching $8.1 million for Q2 2025, compared to $1 million in the previous year. This growth was primarily driven by fees from engineering and licensing work, showcasing the company's expanding business operations. Strong Liquidity Position As of June 30, 2025, NuScale's liquidity, including cash and investments, stood at $489.9 million. This strong liquidity position provides the company with a solid foundation to support its ongoing and future projects. Global Commercialization Partnership with ENTRA1 NuScale has entered into a global commercialization partnership with ENTRA1, where it will provide its power modules to ENTRA1 for the development and financing of energy production plants. This partnership is expected to enhance NuScale's global reach and market presence. Strong Interest in SMR Technology There is growing regulatory support and global interest in NuScale's SMR technology, particularly for applications in data centers and AI systems. This interest underscores the potential of SMR technology in diverse sectors. Expansion of Educational Initiatives NuScale has expanded its educational initiatives by opening two more E2 centers, bringing the total to 11 centers globally. These centers are designed to prepare new nuclear talent, supporting the future of the nuclear industry. Operating Expense Increase Operating expenses for Q2 2025 rose to $44.9 million from $42 million in the prior year. The company anticipates further increases in operating expenses in the second half of 2025 as it advances its procurement processes. Delayed RoPower Project Timeline The timeline for the RoPower project in Romania has been delayed, with the final investment decision now expected in mid-to-late 2026. This delay presents a challenge for the company's project timeline. Decline in Liquidity Compared to Previous Quarter Despite a year-over-year increase, NuScale reported a $31.5 million decline in liquidity from the previous quarter. This decline highlights the financial challenges the company faces in maintaining its liquidity position. Forward-Looking Guidance Looking ahead, NuScale remains focused on securing a commercial order by the end of the year, leveraging its competitive advantage as the only SMR technology with NRC approval. The company anticipates increased operating expenses in the second half of 2025 as it advances the procurement of long-lead materials to bolster its manufacturing and supply chain readiness. In summary, NuScale Power Corporation's earnings call reflects a positive outlook with significant regulatory and revenue advancements, despite facing challenges such as increased operating expenses and project delays. The company's strategic partnerships and educational initiatives are key to strengthening its position in the SMR market, with a focus on securing commercial orders and enhancing its global presence.

Orthopedic Devices Market Poised for 4.78% CAGR Growth Through 2030: FDA Approvals, Breakthrough Device Designation and AI-Enabled Devices Reshape the Market
Orthopedic Devices Market Poised for 4.78% CAGR Growth Through 2030: FDA Approvals, Breakthrough Device Designation and AI-Enabled Devices Reshape the Market

Globe and Mail

time7 hours ago

  • Globe and Mail

Orthopedic Devices Market Poised for 4.78% CAGR Growth Through 2030: FDA Approvals, Breakthrough Device Designation and AI-Enabled Devices Reshape the Market

DelveInsight projects the orthopedic devices market to grow from USD 44.09B in 2023 to USD 57.79B by 2030 at a 4.78% CAGR, driven by rising musculoskeletal disorders and innovation. Key players include Stryker, Zimmer Biomet, Johnson & Johnson, Medtronic, Maxx Orthopedics, Hyalex Orthopaedics, and OrthoPreserve. FDA approvals, AI-enabled devices, and breakthrough technologies like OSCAR PRO, AccelStim, and UNID systems propel market expansion. DelveInsight's ' Orthopedic Devices - Global Market Insights, Competitive Landscape, and Market Forecast - 2030 ' report delivers a comprehensive analysis of the Orthopedic Devices market globally. Key Takeaways Market size projection: As per DelveInsight's analysis, the total market size of Orthopedic Devices globally is expected to surge from USD 44.09 billion in 2023 to USD 57.79 billion by 2030. Patient population data: The report provides the total musculoskeletal disease potential pool, highlighting that 1.71 billion people suffer from conditions such as osteoarthritis, osteoporosis, and rheumatoid arthritis globally, with 528 million osteoarthritis and 18 million rheumatoid arthritis cases in 2019, plus ~300K people living with spinal cord injuries. Key orthopedic device companies: Leading orthopedic device companies, such as Stryker Corporation, Zimmer Biomet, Johnson & Johnson, and Medtronic PLC Pipeline assets: Some of the key orthopedic device innovations in the pipeline include the OSCAR PRO ultrasonic arthroplasty revision system, AccelStim Bone Growth Stimulator, AxSOS Ankle Fusion System, Insignia Hip stem, and AI-enabled UNID spinal fusion devices. In August 2025, the FDA approved the SetPoint System, a neuroimmune modulation device for treating adults with moderately to severely active rheumatoid arthritis. In June 2025, Maxx Orthopedics received FDA 510(k) clearance for their Freedom® Total Knee System Titanium Tibial Base Plate. This approval introduces a new material option, transitioning from CoCrMo to Wrought Titanium-6Aluminium-4Vanadium ELI Alloy (Ti6Al4V ELI) for the tibial base plate component. In May 2025, Hyalex Orthopaedics secured FDA approval of its supplemental Investigational Device Exemption (IDE) application for the Freestyle Knee Implant. In March 2025, Johnson & Johnson MedTech showcased major advances at the American Academy of Orthopaedic Surgeons (AAOS) 2025 Annual Meeting. Building on their momentum from the previous year's 18 FDA 510(k) clearances and 45 global product launches, the company introduced cutting-edge implants, advanced techniques, and data-driven technologies across joint reconstruction, trauma, extremities, and spine specialties. January 2025: OrthoPreserve received Breakthrough Device Designation and enrolled in the FDA TAP program for its Defender meniscus replacement implant. Discover recent advancements in the Orthopedic Devices landscape @ Orthopedic Devices Recent Developments. Orthopedic Devices Market Dynamics The global orthopedic devices market reached USD 44.09 billion in 2023 and is expanding at a compound annual growth rate (CAGR) of 4.78%, projected to attain USD 57.79 billion by 2030. This growth reflects both demographic pressures, an aging population with 54.1 million U.S. residents aged 65 or older as of 2019, and the rising incidence of bone and joint disorders. Musculoskeletal conditions are the leading contributors to disability worldwide, driving substantial demand for implants, supports, and related devices. Orthopedic devices market drivers include the increasing prevalence of osteoarthritis (528 million cases) and osteoporosis, occupational and non-occupational injuries, and technological innovation in implant materials and design. Innovations such as biocompatible titanium constructs and AI-integrated hardware are elevating clinical outcomes and reducing complication rates. For instance, ultrasonic arthroplasty tools like OSCAR PRO facilitate minimally invasive revisions, while AccelStim enhances fracture healing through targeted bone stimulation. The advances in biomechanics, materials science, and regenerative engineering underpin device performance. Titanium interbody cages, porous polymer composites, and smart sensors are enabling load-sharing implants with real-time monitoring. Mechanistically, bone growth stimulators exploit electromagnetic or ultrasonic energy to upregulate osteoblast activity and accelerate fusion. The orthopedic devices innovation and development is robust, with numerous devices in various trial phases. OrthoPreserve's Defender meniscus replacement is in breakthrough designation pathways, and Medtronic's UNID system illustrates the integration of AI in device-guided spinal fusion. Concurrently, Stryker and Zimmer Biomet are conducting post-market surveillance studies to refine long-term safety profiles. The orthopedic devices competitive landscape features diversified strategies: major players invest in in-licensing and partnerships to expand portfolios, while mid-sized innovators focus on niche applications such as ankle and wrist arthrodesis. Strategic M&A activity is anticipated as companies seek to consolidate capabilities in biologics-enabled devices. The orthopedic devices market barriers include regulatory hurdles for novel biomaterials, reimbursement constraints, and potential competition from non-implant therapies (e.g., biologics, cell therapy). However, opportunities abound in emerging markets, tele-enabled surgery, and personalized implant design via 3D printing. The future outlook projects continued growth driven by demographic trends, rising healthcare expenditure, and sustained R&D investment in next-generation orthopedic solutions. Download the Orthopedic Devices Market report to understand which factors are driving the therapeutic market @ Orthopedic Devices Market Trends. Orthopedic Devices Potential Patient Pool Musculoskeletal disorders impact 1.71 billion individuals globally, with 528 million suffering from osteoarthritis and 18 million affected by rheumatoid arthritis as of 2019. Spinal cord injuries afflict approximately 296,000 patients worldwide, with 17,900 new cases annually. DelveInsight's epidemiology segmentation reveals that osteoarthritis accounts for the largest share of years lived with disability, followed by rheumatoid arthritis. The total orthopedic devices eligible patient pools encompass those requiring surgical implants or supportive orthoses, with treated cases driven by healthcare access and device availability. Geographic analysis indicates North America leads market adoption, followed by Europe and Asia-Pacific, where aging demographics and expanding surgical capacity fuel device uptake. Forecasting through 2030 anticipates rising incident cases and an expanding treated cohort as minimally invasive and outpatient surgical centers proliferate. Discover evolving trends in the Orthopedic Devices patient pool forecasts @ Orthopedic Devices Patient Pool Analysis. Key Orthopedic Devices Companies and Competitive Landscape The orthopedic devices sector is anchored by established players and dynamic innovators. Current treatment options range from prophylactic supports (braces, orthoses) to complex implants (total joint prostheses, spinal fusion systems). Stryker Corporation leads with its Insignia Hip stem and AxSOS Ankle Fusion System, leveraging titanium design and updated screw arrays to improve fusion rates. Zimmer Biomet's portfolio includes knee and shoulder implants, while Johnson & Johnson focuses on advanced soft-tissue fixation devices. Medtronic's UNID rods and screws incorporate AI algorithms to optimize spinal alignment intraoperatively. Orthopedic devices development activity features OrthoPreserve's Defender meniscus replacement entering pivotal trials under FDA Breakthrough Device designation and Orthofix's AccelStim in post-approval studies. Key partnerships include licensing agreements for biomaterial coatings and co-development of sensor-enabled implants. Market positioning emphasizes value-based outcomes, with companies forging payor contracts that reward reduced revision rates. Recent milestones encompass FDA clearances (AccelStim May 2022, UNID June 2021), AAOS product launches (Insignia March 2022), and strategic collaborations in 3D-printed implant manufacturing. Commercial arrangements involve joint ventures in emerging markets to enhance distribution networks. Collectively, these efforts define a competitive environment focused on enhancing patient outcomes, expanding indications, and driving long-term growth in the orthopedic devices landscape. Delve deeper into the major and specialised companies in the Orthopedic Devices market @ Orthopedic Devices Competitive Landscape. Conclusion The orthopedic devices market is poised for sustained expansion through 2030, driven by demographic imperatives, technological innovation, and a diversified competitive field. Strategic collaborations, regulatory breakthroughs, and evolving clinical practices will shape the future, ensuring that next-generation implants and support devices meet the growing global demand for improved musculoskeletal health. Table of Contents 1. Orthopedic Devices Market Report Introduction 2. Orthopedic Devices Market Executive Summary 3. Competitive Landscape 4. Regulatory Analysis 5. Orthopedic Devices Market Key Factors Analysis 6. Orthopedic Devices Market Porter's Five Forces Analysis 7. Orthopedic Devices Market Assessment 8. Orthopedic Devices Market Company and Product Profiles 9. KOL Views 10. Project Approach 11. About DelveInsight 12. Disclaimer & Contact Us About DelveInsight DelveInsight is a leading business consulting and market research company focused on the healthcare and life sciences sectors, providing comprehensive market intelligence, competitive landscape analysis, and strategic insights to support decision-making across the pharmaceutical industry. Media Contact Company Name: DelveInsight Business Research LLP Contact Person: Arpit Anand Email: Send Email Phone: +14699457679 Address: 304 S. Jones Blvd #2432 City: Las Vegas State: Nevada Country: United States Website:

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store